The COVID-19 pandemic in different countries: Russia, Brazil and India

Samantha Dos Santos Rocha Ferreira, KYu Koreshkova, Y. Guduru, LS Rocha, L. Perminova
{"title":"The COVID-19 pandemic in different countries: Russia, Brazil and India","authors":"Samantha Dos Santos Rocha Ferreira, KYu Koreshkova, Y. Guduru, LS Rocha, L. Perminova","doi":"10.24075/rbh.2022.044","DOIUrl":null,"url":null,"abstract":"At the end of December 2019, cases of pneumonia of unknown etiology were registered in China. The cause represented by the novel coronavirus SARS-CoV-2 was established later. The infection has spread rapidly around the world. According to the latest official data, over 531,959,093 cases of the infection and over 6,299,068 confirmed COVID-19-related mortality cases were reported in 215 countries. The study aimed to examine characteristic features of the novel coronavirus pandemic in Russia, Brazil, and India from April 2020 to March 2022. Official statistical data on COVID-19-related morbidity, mortality, and vaccination from the websites of the Russian Federal State Agency for Health and Consumer Rights and Johns Hopkins Institute were collected for every country from April 01, 2020, to March 01, 2022. Out of the three examined countries, the highest incidence and mortality for COVID-19 per one million people were found in Brazil, followed by Russia and India respectively. The level of vaccination was the highest in Brazil (73%). It was followed by India (53%) and Russia (50%). The Delta variant of the virus was first identified in India in October 2020. In June of the next year, it accounted for the majority of COVID-19 cases registered in three countries. The same was true for the Omicron variant. Despite the efforts taken within the last two years to contain COVID-19 (development of vaccines, use of other antiepidemic agents), the coronavirus infection is still of cyclical patterns along with increased morbidity. Based on the obtained data, massive vaccination effectively reduced mortality due to COVID-19 though many new variants occurred.","PeriodicalId":119609,"journal":{"name":"Российский вестник гигиены","volume":"44 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2022-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Российский вестник гигиены","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.24075/rbh.2022.044","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

At the end of December 2019, cases of pneumonia of unknown etiology were registered in China. The cause represented by the novel coronavirus SARS-CoV-2 was established later. The infection has spread rapidly around the world. According to the latest official data, over 531,959,093 cases of the infection and over 6,299,068 confirmed COVID-19-related mortality cases were reported in 215 countries. The study aimed to examine characteristic features of the novel coronavirus pandemic in Russia, Brazil, and India from April 2020 to March 2022. Official statistical data on COVID-19-related morbidity, mortality, and vaccination from the websites of the Russian Federal State Agency for Health and Consumer Rights and Johns Hopkins Institute were collected for every country from April 01, 2020, to March 01, 2022. Out of the three examined countries, the highest incidence and mortality for COVID-19 per one million people were found in Brazil, followed by Russia and India respectively. The level of vaccination was the highest in Brazil (73%). It was followed by India (53%) and Russia (50%). The Delta variant of the virus was first identified in India in October 2020. In June of the next year, it accounted for the majority of COVID-19 cases registered in three countries. The same was true for the Omicron variant. Despite the efforts taken within the last two years to contain COVID-19 (development of vaccines, use of other antiepidemic agents), the coronavirus infection is still of cyclical patterns along with increased morbidity. Based on the obtained data, massive vaccination effectively reduced mortality due to COVID-19 though many new variants occurred.
不同国家的COVID-19大流行:俄罗斯、巴西和印度
截至2019年12月底,中国登记了不明原因肺炎病例。以新型冠状病毒SARS-CoV-2为代表的病因是后来确立的。这种传染病在全世界迅速蔓延。根据最新官方数据,215个国家报告了超过531,959,093例感染病例和超过6299,068例与covid -19相关的确诊死亡病例。该研究旨在研究2020年4月至2022年3月期间俄罗斯、巴西和印度新型冠状病毒大流行的特征。从2020年4月1日至2022年3月1日,从俄罗斯联邦国家卫生和消费者权利机构和约翰霍普金斯研究所的网站上收集了每个国家与covid -19相关的发病率、死亡率和疫苗接种的官方统计数据。在被调查的三个国家中,巴西的新冠肺炎每百万人的发病率和死亡率最高,其次是俄罗斯和印度。巴西的疫苗接种水平最高(73%)。紧随其后的是印度(53%)和俄罗斯(50%)。该病毒的Delta变体于2020年10月首次在印度被发现。第二年6月,在三个国家登记的COVID-19病例中,它占了大多数。欧米克隆变异也是如此。尽管在过去两年中为控制COVID-19做出了努力(开发疫苗,使用其他抗流行病药物),但冠状病毒感染仍然具有周期性,发病率也在增加。根据获得的数据,尽管出现了许多新的变异,但大规模疫苗接种有效地降低了COVID-19的死亡率。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信